Shifting focus to oncology, GSK recruits a cancer vet as new chief of US pharmaceuticals — adding another woman to the top ranks of biopharma
The slow-moving overhaul of the leadership and strategy at GSK is taking a fresh turn today, and bringing another woman to the top ranks of the industry.
GlaxoSmithKline said today that US pharmaceuticals president Jack Bailey “has decided to step down” at the end of the year.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 62,800+ biopharma pros reading Endpoints daily — and it's free.